Finally, to better elucidate the clinical and biological relevance of EHMT2 expression, we took advantage of a large cohort of MM patients enrolled in the Multiple Myeloma Research Foundation CoMMpass study (https://research.themmrf.org/ accessed on 26 February 2023). This evidence concerns the gene EHMT2 and plasma cell myeloma.